OpGen Announces Exercise of All Prefunded Warrants

February 17, 2023

https://www.globenewswire.com/news-release/2023/02/17/2610568/35690/en/OpGen-Announces-Exercise-of-All-Prefunded-Warrants.html

ROCKVILLE, Md., Feb. 17, 2023 (GLOBE NEWSWIRE) — OpGen, Inc. (Nasdaq:OPGN, “OpGen” or “the Company”), a precision medicine company harnessing the power of molecular diagnostics and bioinformatics to help combat infectious disease, today announced that all of the prefunded warrants that were issued in its public offering that closed on January 11, 2023 have been exercised in full. In light of the exercise of the 2,265,000 prefunded warrants issued in the public offering, the Company has issued an equal number of common shares, resulting in a total number of shares outstanding as of February 15, 2023 of 5,483,919. As of February 16, 2023, no prefunded warrants remain outstanding.

Read more at globenewswire.com

Related news for (OPGN)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.